<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <managingEditor>CEVA</managingEditor>
        <description>CEVA RSS Feed</description>
        <pubDate>Mon, 11 May 2026 11:11:36 +0200</pubDate>
        <language>eng-GB</language>
        <docs>http://www.rssboard.org/rss-specification</docs>
        <title>Ceva Animal Health (Philippines), Inc. RSS</title>
        <link>https://www.ceva.ph/</link>
        <item>
            <title>Ceva launches Vectormune HVT-AIV in the Philippines</title>
            <link>https://www.ceva.ph/News-Media/News/https-avinews.com-en-ceva-launches-vectormune-hvt-aiv-in-the-philippines</link>
            <guid>https://www.ceva.ph/News-Media/News/https-avinews.com-en-ceva-launches-vectormune-hvt-aiv-in-the-philippines</guid>
            <description><![CDATA[The vaccine offers cross-clade protection, single-shot application, and lasting immunity, strengthening poultry resilience against recurring avian influenza outbreaks.]]></description>
            <pubDate>Wed, 3 Dec 2025 06:02:41 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Philippines Leads Innovation at Philippine Poultry Show &amp; ILDEX Philippines 2025</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Leads-Innovation-at-Philippine-Poultry-Show-ILDEX-Philippines-2025</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Leads-Innovation-at-Philippine-Poultry-Show-ILDEX-Philippines-2025</guid>
            <description><![CDATA[     Ceva Philippines proudly participated as a Gold Sponsor at the Philippine Poultry Show and ILDEX Philippines 2025, held from August 27 to 29 at the SMX Convention Center in Manila, showcasing its unwavering commitment to innovation and the advancement of the local poultry industry. Throughout the event, Ceva featured its latest technologies and solutions, including the Desvac Smart Hatch Spray and Gel for efficient hatchery vaccination, IMVAC Safe for reliable immunization, and its comprehensive Ceva Poultry Solutions portfolio— Nextmune, Immucox, and Megamune—designed to strengthen immunity and protect flocks. Attendees also learned about Ceva’s strategic programs such as the Less Is More initiative, which promotes optimized vaccine usage, and the CHICK Program services, offering operational support and quality assurance for hatcheries.   A key highlight was the Poultry Forum Seminar, where Dr. Mark Andrew Cuento, Ceva Philippines’ Veterinary Services Manager, presented on Cutting-Edge Vaccine Technologies for Avian Influenza Prevention, reinforcing Ceva’s leadership in disease control and vaccine innovation. As a Gold Sponsor, Ceva’s presence underscored its dedication to empowering Filipino poultry producers through technology, education, and long-term partnerships that drive industry growth and sustainability.    ]]></description>
            <pubDate>Fri, 14 Nov 2025 16:11:45 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Philippines Hosts Layer Day 2025: Science-Driven Solutions for Respiratory Integrity</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Hosts-Layer-Day-2025-Science-Driven-Solutions-for-Respiratory-Integrity</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Hosts-Layer-Day-2025-Science-Driven-Solutions-for-Respiratory-Integrity</guid>
            <description><![CDATA[  Ceva Philippines proudly held Ceva Layer Day 2025 last September 3, 2025, at the Crimson Manila Hotel, gathering over 100 layer and breeder producers from across the country. With the theme “Respiratory Integrity in Layers: Science, Strategy and Solutions,” the event served as a valuable platform for learning, collaboration, and industry connection. Designed to combine technical insights with a relaxed and enjoyable setting, the event fulfilled its goal of strengthening partnerships and driving progress in the Philippine poultry sector.   The program featured a strong lineup of expert speakers. Atty. Irwin Ambal, a layer farmer and former president of the National Egg Board, opened the day with key industry updates and outlook. Dr. Butch Yabut, a poultry consultant and diplomate of the Philippine College of Poultry Practitioners, discussed the most relevant diseases affecting layers. Jessica Lee, Ceva’s Global Veterinary Services Manager, tackled co-infections and the importance of proper diagnosis, while Seçkin Sandikli, Ceva’s Global Marketing Director, addressed the rising concern of Avian Influenza and Ceva’s global response.   A major highlight of the event was the introduction of Ceva’s “Less Is More” program, which promotes smarter, more efficient disease management — reducing interventions while maximizing flock health. Beyond the technical sessions, the event featured live music and interactive segments, making it not only informative but also fun and engaging for all attendees. Ceva Layer Day 2025 was a true success, reflecting Ceva’s commitment to innovation, partnership, and shared growth in the poultry industry.]]></description>
            <pubDate>Thu, 13 Nov 2025 20:06:04 +0100</pubDate>
        </item>
        <item>
            <title>Ceva at Livestock Philippines: Advancing Vaccination to Curb AMR</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-at-Livestock-Philippines-Advancing-Vaccination-to-Curb-AMR</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-at-Livestock-Philippines-Advancing-Vaccination-to-Curb-AMR</guid>
            <description><![CDATA[At Livestock Philippines 2025, Informa Markets hosted the forum “From Policies to Practice – Tackling Antimicrobial Resistance Together,” spotlighting strategies to address antimicrobial resistance (AMR) in animal agriculture and public health.   Dr. Michael Constante, National Veterinary Services Manager – Poultry at Ceva Animal Health Philippines Inc., presented “Vaccination as an Alternative to Antibiotics,” emphasizing the distinct roles of vaccines and antibiotics. Vaccines prevent diseases by priming the immune system, while antibiotics treat bacterial infections after animals fall ill. Misusing antibiotics—especially for viral infections—accelerates AMR.     Dr. Constante highlighted vaccination as a key strategy to reduce antibiotic use and curb AMR. Even vaccines for viral diseases help by preventing secondary bacterial infections, lowering the need for antibiotics. Vaccination also promotes herd immunity, protecting vulnerable animals.   A major challenge in early-life vaccination is maternal antibody interference. Ceva’s immune-complex vaccines, like the Infectious Bursal Disease (IBD) vaccine for poultry, overcome this by shielding antigens from maternal antibodies, ensuring effective immune responses. Similar innovations for pigs are in development.   Globally, vaccination is recognized by organizations like WOAH, FAO, and WHO as a cost-effective, sustainable approach to combat AMR. Ceva continues to advance vaccine technologies to support this mission.  ]]></description>
            <pubDate>Fri, 15 Aug 2025 01:52:12 +0200</pubDate>
        </item>
        <item>
            <title>AUPHYL® Plus</title>
            <link>https://www.ceva.ph/Products/Products-list/AUPHYL-R-Plus</link>
            <guid>https://www.ceva.ph/Products/Products-list/AUPHYL-R-Plus</guid>
            <description><![CDATA[Dosage and Administration: Reconstitute the vaccine with AUPHYL PLUS diluent and shake well. Should be administered IM in the neck behind the ear. Dosage: 2 ml per animal Fatteners - 1 single vaccination at the age of 8-10 weeks is sufficient to protect animals in moderately infected areas. - In case of severe infection, vaccinate the pigs at 8 weeks and then at 11 or 12 weeks. Breeders - Primovaccination:2 injections at 1 month interval as above - Booster: 3 weeks before farrowing In case of disease outbreak vaccinate immediately after the first clinical cases to control the spread of the infection. Indication: Prevention of all clinical manifestations of Aujeszky&#039;s disease including the respiratory form. Eradication program of Aujeszky&#039;s disease in pigs Storage Condition: Liophylisate: store refrigerated (+2 °C- 8 °C). Protect from light. Solvent: store refrigerated (+2 °C- 8 °C). Protect from light. Do not freeze! Pack Size: The vaccine is put into circulation in 10 ml glass vials containing 10, 25 and 50 doses of vaccine. The vials are sealed with rubber stoppers and metal caps. Presentation: 10, 25 and 50 doses of freeze-dried vaccine, and 20, 50 and 100 ml of oily emulsion (oil-in-water type adjuvant) as diluent.]]></description>
            <pubDate>Tue, 27 May 2025 12:57:16 +0200</pubDate>
        </item>
        <item>
            <title>Nextmune®</title>
            <link>https://www.ceva.ph/Products/Products-list/Nextmune-R</link>
            <guid>https://www.ceva.ph/Products/Products-list/Nextmune-R</guid>
            <description><![CDATA[Dosage and Administration: The vaccine can be administered by in ovo or subcutaneous routes. Use sterile devices and equipment for reconstitution and for administration of the vaccine. The usual aseptic precautions should be applied. Users must be familiar with all safety and precautionary measures for handling liquid nitrogen in order to prevent personal injury. Match the dose size of the vaccines and the sterile solvent according to the tables below. In-ovo administration One single dose of 0.05 ml is injected into each 18-day-old embryonated broiler chicken egg using in-ovo equipment. The vaccine is delivered to the amnion sac. Proposed dilutions for In-ovo administration: Number of vaccine ampoules - Solvent - Volume of one dose 4 x 2000 doses - 400 mL - 0.05 mL 2 x 4000 doses - 400 mL - 0.05 mL 4 x 4000 doses - 800 mL - 0.05 mL 1 x 8000 doses - 400 mL - 0.05 mL 2 x 8000 doses - 800 mL - 0.05 mL 3 x 8000 doses - 1200 mL - 0.05 mL 4 x 8000 doses - 1600 mL - 0.05 mL Subcutaneous administration One single injection of 0.2 ml per chick is applied at one day of age. Automatic syringe may be used. The vaccine is delivered under the skin of the neck. Proposed dilutions for subcutaneous administration: Number of vaccine - Solvent - Volume of one dose 1 x 2000 doses - 400 mL - 0.2 mL 2 x 2000 doses - 800 mL - 0.2 mL 3 x 2000 doses - 1200 mL - 0.2 mL 4 x 2000 doses - 1600 mL - 0.2 mL 1 x 4000 doses - 800 mL- 0.2 mL 2 x 4000 doses - 1600 mL - 0.2 mL Indication: For the active immunization of broiler chickens in order to reduce mortality, clinical signs, weight loss, acute lesions of bursa of Fabricius and to prevent virus shedding caused by classical and very virulent strains of Infectious Bursal Disease virus. The onset of immunity is expected from 3 weeks of age depending on the initial maternally derived antibodies (MDA) level. The duration of immunity is demonstrated until 7 weeks of age.]]></description>
            <pubDate>Sat, 24 May 2025 17:25:38 +0200</pubDate>
        </item>
        <item>
            <title>IMMUCOX® 5</title>
            <link>https://www.ceva.ph/Products/Products-list/IMMUCOX-R-5</link>
            <guid>https://www.ceva.ph/Products/Products-list/IMMUCOX-R-5</guid>
            <description><![CDATA[COMPOSITION IMMUCOX® 5 contains live, sporulated oocysts of Eimeria acervuline. E maxima, E tenella, E. necatrix and E brunetti in a liquid suspension. INDICATIONS IMMUCOX® 5 is designed for the purpose of delivering uniformly low doses of live oocysts to chickens to aid in the development of immunity against coccidiosis. When administered according to the directions IMMUCOX®5 can prevent mortality cause by Eimeria acervuline, E, maxima, E. tenella, E, necatrix and E brunetti ADMINISTRATION AND DOSAGE For 10,000 doses of IMMUCOX® Gel-Droplet 1. Add 70g of CevaGel diluent to 2.5L of distilled water. Mix well with a blender 2. Add 10,000 doses of IMMUCOX 5 vaccine to the CevaGel solution and mix with a blender. 3. Spray 25mL of vaccine per 100 birds using a gel spray equipment. STORAGE -Store vaccine between +2°C and +8°C (35°F and 45°F) -DO NOT FREEZE PACKAGED 10 x 1,000 doses vials/box 10 ml vials]]></description>
            <pubDate>Wed, 7 May 2025 11:33:05 +0200</pubDate>
        </item>
        <item>
            <title>IMMUCOX® 3</title>
            <link>https://www.ceva.ph/Products/Products-list/IMMUCOX-R-3</link>
            <guid>https://www.ceva.ph/Products/Products-list/IMMUCOX-R-3</guid>
            <description><![CDATA[COMPOSITION IMMUCOX®3 contains a live, sporulated oocysts of Eimeria acervuline, Eimeria maxima and Eimeria tenella in a liquid suspension. INDICATIONS IMMUCOX 3 is designed for the purpose of delivering uniformly optimum doses of live oocysts to chickens to aid in the development of immunity against coccidiosis. When administered according to the directions (see below) IMMUCOX®3 can prevent coccidiosis caused by E acervuline, E. maxima and E tenella. ADMINISTRATION AND DOSAGE For 10,000 doses of IMMUCOX® Gel-Droplet 1. Add 70g of CevaGel diluent to 2.5L of distilled water. Mix well with a blender. 2. Add 10,000 doses of IMMUCOX 3 vaccine to the CevaGel solution and mix with a blender. 3. Spray 25mL of vaccine per 100 birds using a gel spray equipment STORAGE -Store vaccine between +2°C and +8°C (35°F and 45°F) DO NOT FREEZE PACKAGED 10 x 5,000 doses Each vial contains 10 ml]]></description>
            <pubDate>Wed, 7 May 2025 11:23:01 +0200</pubDate>
        </item>
        <item>
            <title>CEVAC® MEGAMUNE K</title>
            <link>https://www.ceva.ph/Products/Products-list/CEVAC-R-MEGAMUNE-K</link>
            <guid>https://www.ceva.ph/Products/Products-list/CEVAC-R-MEGAMUNE-K</guid>
            <description><![CDATA[COMPOSITION CEVAC® MEGAMUNE K is an inactivated multivalent vaccine recommended for the vaccination of layer and breeder type chicken flocks.  VACCINE TYPE &amp; STRAIN Inactivated oil emulsion vaccine - Newcastle disease virus- strain NDV-SZ LaSota - Avian Infectious Bronchitis virus-strain M-41 - Avian Infectious Bronchitis virus-strain QX Fr - Egg Drop Syndrome virus-strain B8/78 -Avian Metapneumovirus-strain TRT50 INDICATIONS CEVAC® MEGAMUNE K is recommended for the vaccination of layer and breeder type chicken flocks, in order to reduce mortality, clinical signs, lesions and virus shedding. caused by Newcastle disease virus; - to reduce egg drop, respiratory signs and virus shedding caused by the Massachusetts and QX-like serotypes of Infectious bronchitis virus, - to reduce egg drop caused by the Egg drop syndrome virus, -to reduce respiratory signs (e.g. signs linked to Swollen Head Syndrome) and virus shedding caused by Avian metapneumovirus.es.  ADMINISTRATION AND DOSAGE The dose of the vaccine is.0.5 ml, injected by intramuscular route (into breast muscles) or subcutaneously (into the back of the neck) from 14 weeks of age, no later than 3 weeks before expected onset of the laying period  STORAGE -Store and transport vaccine between +2°C and +8°C -Protected from light -Do not freeze PACKAGED 1,000 doses/500 ml WARNING This product contains oil based adjuvant; accidental injection into a human may cause a serious localized reaction. Seek expert medical attention immediately.]]></description>
            <pubDate>Wed, 7 May 2025 11:13:19 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Philippines Chick Day 2025: Where Innovation Meets Collaboration</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Chick-Day-2025-Where-Innovation-Meets-Collaboration</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Chick-Day-2025-Where-Innovation-Meets-Collaboration</guid>
            <description><![CDATA[Ceva Philippines recently hosted its highly successful annual event, Ceva Chick Day 2025, on February 27, 2025.]]></description>
            <pubDate>Thu, 24 Apr 2025 17:25:21 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Swine Day 2025: Empowering the Swine Industry</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Swine-Day-2025-Empowering-the-Swine-Industry</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Swine-Day-2025-Empowering-the-Swine-Industry</guid>
            <description><![CDATA[On March 26, 2025, Ceva Philippines proudly hosted the Ceva Swine Day in Pasay City, Manila.]]></description>
            <pubDate>Thu, 24 Apr 2025 12:54:03 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Philippines and BEPA: Nurturing the Future Together</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-and-BEPA-Nurturing-the-Future-Together</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-and-BEPA-Nurturing-the-Future-Together</guid>
            <description><![CDATA[On March 19, 2025, the vibrant community of Pandi, Bulacan witnessed a heartwarming event at
Manatal Elementary School. Ceva Philippines, in collaboration with the Bulacan Egg Producers
Association (BEPA).]]></description>
            <pubDate>Thu, 24 Apr 2025 12:33:58 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Philippines Showcases Expertise at 31st National Hog Convention</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Showcases-Expertise-at-31st-National-Hog-Convention</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Showcases-Expertise-at-31st-National-Hog-Convention</guid>
            <description><![CDATA[Ceva Philippines proudly participated as a Patron Sponsor in the 31st National Hog Convention and Trade Exhibits held from March 27-29 in Pasay City.]]></description>
            <pubDate>Thu, 24 Apr 2025 12:16:08 +0200</pubDate>
        </item>
        <item>
            <title>Ceva’s Commitment to Poultry Health Highlighted at the 6th WVPA Asia Meeting, Manila Philippines</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-s-Commitment-to-Poultry-Health-Highlighted-at-the-6th-WVPA-Asia-Meeting-Manila-Philippines</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-s-Commitment-to-Poultry-Health-Highlighted-at-the-6th-WVPA-Asia-Meeting-Manila-Philippines</guid>
            <description><![CDATA[Ceva Animal Health showcased its commitment to poultry health and disease preparedness at the 6th WVPA Asia Meeting in Manila, Philippines]]></description>
            <pubDate>Tue, 12 Nov 2024 08:20:46 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Philippines’ Remarkable Presence at the Poultry School Convention 2024</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Remarkable-Presence-at-the-Poultry-School-Convention-2024</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Remarkable-Presence-at-the-Poultry-School-Convention-2024</guid>
            <description><![CDATA[Ceva Philippines showcased their commitment to poultry health and innovation at the Poultry School Convention 2024 through impactful presentations and networking.]]></description>
            <pubDate>Tue, 12 Nov 2024 05:09:01 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Philippines at the Philippine Poultry Show and ILDEX Philippines 2024: Committed to Poultry Success</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-at-the-Philippine-Poultry-Show-and-ILDEX-Philippines-2024-Committed-to-Poultry-Success</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-at-the-Philippine-Poultry-Show-and-ILDEX-Philippines-2024-Committed-to-Poultry-Success</guid>
            <description><![CDATA[Ceva Philippines showcased their commitment to poultry industry success at the Philippine Poultry Show &amp; ILDEX Philippines 2024 by unveiling new products and fostering strong industry relationships.]]></description>
            <pubDate>Tue, 12 Nov 2024 04:46:30 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Philippines’ Contribution to our #OnePlanet Purpose through a Tree Planting Activity for WeShare</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Contribution-to-our-OnePlanet-Purpose-through-a-Tree-Planting-Activity-for-WeShare</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Philippines-Contribution-to-our-OnePlanet-Purpose-through-a-Tree-Planting-Activity-for-WeShare</guid>
            <description><![CDATA[Ceva Philippines demonstrated their commitment to environmental stewardship by planting 40 trees as part of their #OnePlanet initiative during a WeShare activity.]]></description>
            <pubDate>Tue, 12 Nov 2024 04:24:54 +0100</pubDate>
        </item>
        <item>
            <title>Press Release</title>
            <link>https://www.ceva.ph/News-Media/News/Press-Release</link>
            <guid>https://www.ceva.ph/News-Media/News/Press-Release</guid>
            <description><![CDATA[Libourne, January 25, 2024 – Ceva Santé Animale (Ceva), the #5 animal health company present in 110 countries worldwide, announces the strategic acquisition of Scout Bio, a pioneer in biotechnology focused on cutting-edge therapies for pets. The move represents a significant leap in innovation for Ceva, unlocking access to key advancements including a pipeline of monoclonal antibodies and gene therapy developments to address chronic diseases in pets.     While maintaining strong positions and continuing to develop biological and preventive medicine for all species, with this strategic acquisition Ceva aims to boost its global biotechnology activities, drawing on Scout Bio&#039;s heritage but more importantly, fostering a future characterized by the acceleration of biotherapeutic innovation.   Scout Bio, renowned for its commitment to innovation, has been at the forefront of developing groundbreaking biotherapeutic products. This acquisition underscores Ceva&#039;s recognition of Scout Bio&#039;s nimble and responsive approach, as well as its excellence in clinical study execution in the biotherapeutics space.   Mark Heffernan , former CEO of Scout Bio, who has joined Ceva as Senior Vice President of Biotherapeutics and CEO of Ceva Biotechnology Campus (Philadelphia) expressed his enthusiasm by declaring:     &quot;With this acquisition, Ceva is ready to write a new chapter. The strength of the Group, which is one of the leaders in animal health, will propel our existing and future initiatives to new heights. Ceva has not only recognized our team’s delivery on innovation, but also our commitment to execution of quality clinical studies. With the power of Ceva, we will be able to accelerate biotherapeutic innovation for the well-being of pets and the happiness of their owners.”   In a commitment to continuity, Ceva will maintain a strong relationship with the world-renowned Gene Therapy Program (GTP) at the University of Pennsylvania, from where Scout Bio originated as a spin-out from Dr. James M. Wilson&#039;s lab. Dr. Wilson is director of the Gene Therapy Program, the Rose H. Weiss Professor and director at the Orphan Disease Center, a professor of Medicine and Pediatrics in the Perelman School of Medicine at the University of Pennsylvania, and a pioneer in the field of gene therapy. Together, Scout Bio and Penn’s Gene Therapy Program have jointly developed multiple programs in this emerging field, and Ceva aims to build further upon this success. The collaboration will progress existing programs and explore new product development opportunities where these types of disruptive technologies can be applied for the advancement of animal health.   &quot;The recent acquisition of Scout Bio by Ceva marks a pivotal moment in the advancement of pet therapeutics. This integration of expertise, resources, and a shared commitment to innovation opens new horizons for Ceva. Indeed, with the growing trend of &#039;pet humanization,&#039; owners aspire to extend the lives and well-being of their four-legged companions. This strategic alliance offers us the opportunity to develop products and solutions that cater to these expectations. Together, we are poised to lead in shaping the future of biotherapeutic solutions for the well-being of pets worldwide.” said Dr. Marc Prikazsky, Chairman and CEO of Ceva.    Marc Prikazsky / Mark Heffernan   About Ceva Santé Animale   Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.   With 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.      2022 turnover: €1.5 billion.   www.ceva.com      University of Pennsylvania Financial Disclosure   Dr. Wilson is a Penn faculty member, scientific collaborator, key advisor, and co-founder of Scout Bio. As such, he received an equity stake in the company, his laboratory at Penn received sponsored research funding from Scout Bio, and as an inventor of certain Penn intellectual property licensed to Scout Bio (now licensed post-acquisition to Ceva), Dr. Wilson may receive additional financial benefits in the future. The University of Pennsylvania also received sponsored research funding from Scout Bio, received equity in Scout Bio, and has licensed intellectual property to Scout Bio (now Ceva) that may result in future financial returns to Penn. ]]></description>
            <pubDate>Thu, 1 Feb 2024 03:09:36 +0100</pubDate>
        </item>
        <item>
            <title>Ceva supports the Eat Pinoy Pork movement</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-supports-the-Eat-Pinoy-Pork-movement</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-supports-the-Eat-Pinoy-Pork-movement</guid>
            <description><![CDATA[Ceva Animal Health (Phils) Inc. supports the Pork Producers Federation of the Philippines in its campaign to support locally produced pork. The movement aims to share the benefits of consuming local pork, in this case, helping the local farm workers.   In its IN-PORK-MATION: The next time you shop for your favorite pork cuts, don&#039;t pork-get to always choose TATAK FRESH! MAS MALINIS, MAS MASARAP, ANG SARIWA! Eat Pinoy Pork! Don&#039;t pork-get to like and share! Join the movement now!   To get the latest news and updates from Pork Producers Federation of the Philippines, don&#039;t pork-get to follow our official Facebook page: https://www.facebook.com/Pork-Producers-Federation-of-the-Phils-Inc-161673517213246 #MasMalinisMasMasarapAngSariwa #EatPinoyPork #PorkProducersFederation ]]></description>
            <pubDate>Thu, 2 Sep 2021 03:30:56 +0200</pubDate>
        </item>
        <item>
            <title>&quot;Why do they buy our pork?&quot;: A Ceva Swine Asia 2021 Webinar Offering </title>
            <link>https://www.ceva.ph/News-Media/News/Why-do-they-buy-our-pork-A-Ceva-Swine-Asia-2021-Webinar-Offering</link>
            <guid>https://www.ceva.ph/News-Media/News/Why-do-they-buy-our-pork-A-Ceva-Swine-Asia-2021-Webinar-Offering</guid>
            <description><![CDATA[Ceva Animal Health in Asia partners with the swine farmers in the region as it regains footing amidst the African swine fever (ASF) onslaught. And one of the best ways to help is by empowering key stakeholders to make informed decisions through knowledge sharing. On March 11, 2021, Ceva Swine Asia will hold its first webinar for 2021 entitled &quot; Why do they buy our pork?&quot;. Discussions will revolve around current pork consumer trends and antibiotic restrictions in swine production.     The guest speakers for this session will be Mr. Guillem Burset, owner of an international pig meat trading company. His professional path in meats started in 1977 as a manager at Jaume Abras, S.A. In 1986 he was elected President of the Meat Industries Catalan Federation (FECIC), a position he held until 1989. Mr. Burset worked for ESS-FOOD Spain, a multinational Danish pig meat trading company between 1990 and 1993. A founding partner of Grup Unexporc S.A. in 1994, he helped establish the export of Spanish pig meat with the group until 2005 when he left to create his own trading company.    Dr. Daniel Sperling is Ceva Swine&#039;s Corporate Technical Manager. He started his career as an academician at the University of Veterinary and Pharmaceutical Sciences Brno, his alma mater, first as a researcher then as an Assistant Professor in the Ruminant and Swine Clinic. He holds a PhD from the Institute of Microbiology and Infectious Diseases specializing in enteric diseases of swine. He holds 4 years of swine consultancy experience in the Czech Republic and more than 12 years of involvement in the animal pharmaceutical industry.   ]]></description>
            <pubDate>Thu, 25 Feb 2021 02:37:37 +0100</pubDate>
        </item>
        <item>
            <title>PROGRESSIS®</title>
            <link>https://www.ceva.ph/Products/Products-list/PROGRESSIS-R</link>
            <guid>https://www.ceva.ph/Products/Products-list/PROGRESSIS-R</guid>
            <description><![CDATA[Progressis ® is Ceva’s inactivated PRRSV vaccine. It targets reproductive animals, especially to boost immunity originally obtained by vaccination with an MLV vaccine or by field infection. Its obvious advantage over MLV vaccines is it safety profile; because of its inactivated nature it will not replicate in the vaccinated animal, mutate or spread.     COMPOSITION   Each 2-ml dose of vaccine contains:   Active substance: Inactivated Porcine Reproductive and Respiratory Syndrome (PRRS) virus, P120 strain, 2.5 log 10 IF* units. *IF units: ImmunoFluorescence antibody titre obtained after 2 injections in pigs under specific laboratory conditions.   Adjuvant: O/W oily excipient q.s. 1 dose of 2 ml.     INDICATION   Reduction of the reproductive disorders caused by Porcine Reproductive and Respiratory Syndrome virus in a contaminated environment: vaccination reduces the number of early farrowings and the number of stillbirths.   In PRRS infected herds, viral infection is heterogeneous and varies over time. In such context, the implementation of a vaccination program is a tool to improve the reproductive parameters and may contribute to the disease control in conjunction with sanitary measures.     HOW TO USE PROGRESSIS?   One dose of 2 ml is administered by deep intramuscular route, in the neck muscles behind the ear, according to the following vaccination scheme:   Primary vaccination: Gilts: 2 injections 3-4 weeks apart, at least 3 weeks before mating. Sows: 2 injections 3-4 weeks apart (vaccination of all the sows of the herd within a short period is recommended).   Revaccination: One injection at 60-70 days of each gestation, as of the first gestation following the primary vaccination.     WITHDRAWAL PERIOD   Zero days.]]></description>
            <pubDate>Thu, 12 Nov 2020 08:35:07 +0100</pubDate>
        </item>
        <item>
            <title>ENZAPROST® T</title>
            <link>https://www.ceva.ph/Products/Products-list/ENZAPROST-R-T</link>
            <guid>https://www.ceva.ph/Products/Products-list/ENZAPROST-R-T</guid>
            <description><![CDATA[Composition Dinoprost 5 mg, Excipient q. s. 1 ml    Indications Post partum use: reduction of the weaning to oestrus interval (WOI) in sows with puerperal problems such as metritis in herds with reproductive problems.    Contra-indications Do not administer to pregnant animals, unless it is desirable to induce parturition or interruption of pregnancy.    Posology Post-partum use : One administration of 2 ml of ENZAPROST®T per animal 24 to 36 hours after parturition.    Special precautions Pregnant women, asthmatics and persons with bronchial and other respiratory problems should not use the product or wear disposable plastic gloves.     Withdrawal period   Meat and offal: 2 days    Storage No special precautions for storage. After first opening: do not store above 25 °C. Packaging Vials of 5 ml, 10 ml, 30 ml and 50 ml.]]></description>
            <pubDate>Wed, 11 Nov 2020 09:11:54 +0100</pubDate>
        </item>
        <item>
            <title>Cevac NB L</title>
            <link>https://www.ceva.ph/Products/Products-list/Cevac-NB-L</link>
            <guid>https://www.ceva.ph/Products/Products-list/Cevac-NB-L</guid>
            <description><![CDATA[COMPOSITION CEVAC® NB L contains the Massachusetts B48 strain of Infectious Bronchitis virus and the La Sota strain of Newcastle Disease virus in live, freeze dried form. The embryonated hen eggs used in the production of the vaccine are obtained from specified-pathogen-free (SPF) flocks. INDICATIONS For the active immunisation of healthy chickens against Infectious Bronchitis and Newcastle Disease. The vaccine may be used for initial vaccination or re-vaccination of broilers, pullets and hens. STORAGE - Store vaccine between +2°C and +8°C or 35°F and 45°F - Protect from light PACKAGED 1,000 and 2,500 dose vials 20 x 1,000 dose vials / box 20 x 2,500 dose vials / box WARNING Newcastle Disease virus may cause a mild inflammation of the eye in humans which lasts for two or three days. Care should therefore be taken when handling the virus to avoid contact with the eyes.]]></description>
            <pubDate>Wed, 11 Nov 2020 03:38:55 +0100</pubDate>
        </item>
        <item>
            <title>Ceva Poultry Asia concludes Season 1: e-Ceva University</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Poultry-Asia-concludes-Season-1-e-Ceva-University</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Poultry-Asia-concludes-Season-1-e-Ceva-University</guid>
            <description><![CDATA[  Learning was made easier for our poultry partners despite the global pandemic caused by Covid-19. To bring more value to our beloved poultry raisers and veterinarians, Ceva Poultry Asia held a weekly session online through Facebook live through e-Ceva University: Meet the Experts. For 14 consecutive weeks, global experts were invited to share their knowledge and experience in various aspects of poultry farming via an hour long online session. On October 16, season 1 concluded with a session highlighting the key points of each presentation in the previous episodes - the 15th episode was a celebration and our way of thanking the more than 100,000 viewers who took time out to know more about poultry raising.   To know more about Ceva Poultry Asia activities, like and share our page in the link below:   https://www.facebook.com/cevapoultryasia    ]]></description>
            <pubDate>Wed, 11 Nov 2020 03:23:54 +0100</pubDate>
        </item>
        <item>
            <title>COVID-19 - UPDATE TO OUR CUSTOMERS</title>
            <link>https://www.ceva.ph/News-Media/News/COVID-19-UPDATE-TO-OUR-CUSTOMERS</link>
            <guid>https://www.ceva.ph/News-Media/News/COVID-19-UPDATE-TO-OUR-CUSTOMERS</guid>
            <description><![CDATA[  We face together an extraordinary situation where the world is going into lockdown to face the very real threat posed by Covid-19.   I wanted to assure you that Ceva is taking every contingent step possible, to firstly protect our own employees (and ensure they don’t contaminate others) and then to make sure that we continue to provide you our customers with the products, equipment and services essential to your operations. I have no wish to add to the plethora of communications around Covid-19, except to say that Ceva will do everything within our power to support you, our most valued customers.  MANUFACTURING AND SUPPLY Our global manufacturing and supply chain is fully engaged in managing resources and shipments to and from our facilities. Thanks to our robust inventory planning, so far we have had no impact on product availability. For our strategic vaccines and pharmaceutical products, we always carry several months of safety stocks.    All our global manufacturing plants continue to run as normally as possible with the health and well-being of our workers being our primary concern. I would like to publicly thank them for their sense of civic duty in continuing to produce the animal health products our customers rely on.   Ceva’s local teams are engaging with all customers to elaborate the best plan to support continuity of supply. Local and Global business contingency teams are constantly monitoring this very fluid environment and we will of course keep you fully informed should matters change.   Please if you have any more specific questions direct them to your immediate Ceva contact and if necessary, use this address: corporate.communication@ceva.com THE VITAL ROLE OF ANIMAL HEALTH IN OUR SOCIETY As veterinarians, farmers, pet owners or animal health workers you all know the vital role animals play in our society.   As we ask many people to avoid contact with other people, pets will play an extremely important role in providing companionship to the most vulnerable groups, particularly older people whose mental and physical health could otherwise be severely affected by such isolation. Although, in many parts of the world we take for granted the supply of inexpensive and plentiful food, this crisis will strain our supply chains to the limit and maybe help society to better understand the value that livestock farming brings to our communities. Our Ceva value of solidarity fits this challenge perfectly.   To all our customers and especially my fellow veterinarians, your role in this crisis is key, you have my commitment that we are together with you, and as One Ceva.   Marc Prikazsky Chairman &amp; CEO Ceva Santé Animale]]></description>
            <pubDate>Wed, 11 Nov 2020 02:24:32 +0100</pubDate>
        </item>
        <item>
            <title> VECTORMUNE® ND-RISPENS</title>
            <link>https://www.ceva.ph/Products/Products-list/VECTORMUNE-R-ND-RISPENS</link>
            <guid>https://www.ceva.ph/Products/Products-list/VECTORMUNE-R-ND-RISPENS</guid>
            <description><![CDATA[Vectormune ® ND Rispens is recommended for use in healthy day-old chicks or in 18-21 day-old embryonated chicken eggs as an aid in the prevention of Newcastle disease and Marek&#039;s disease caused by very virulent Marek&#039;s disease.]]></description>
            <pubDate>Thu, 29 Oct 2020 09:29:09 +0100</pubDate>
        </item>
        <item>
            <title>NOVAMUNE</title>
            <link>https://www.ceva.ph/Products/Products-list/NOVAMUNE</link>
            <guid>https://www.ceva.ph/Products/Products-list/NOVAMUNE</guid>
            <description><![CDATA[The immune complex vaccine in hatchery for layers that stops the Gumboro cycle - stops re-infection and protects against all IBD virus strains, and allows to simplify the vaccine program for full protection of layer flocks.]]></description>
            <pubDate>Thu, 29 Oct 2020 02:37:02 +0100</pubDate>
        </item>
        <item>
            <title>FORCERIS</title>
            <link>https://www.ceva.ph/Products/Products-list/FORCERIS</link>
            <guid>https://www.ceva.ph/Products/Products-list/FORCERIS</guid>
            <description><![CDATA[Iron is an essential micronutrient in piglets. It plays a major role in the transport of oxygen via hemoglobin and myoglobin, as well as having a key role in enzymes, such as cytochromes, catalases and peroxidases. Injectable iron-carbohydrate complexes, such as gleptoferron, are established hematinic agents in veterinary medicine and are effective in significantly increasing the hemoglobin levels in piglets raised under intensive farming conditions in which an all-milk diet for several weeks does not provide an adequate source of iron. Following intramuscular injection, gleptoferron is absorbed and metabolized to release the iron for use and/or storage in accordance with the nutritional status of the animals. Excess iron in principally stored in the liver.   Toltrazuril is a triazinon derivative and an anti-protozoan agent. It has coccidiocidal activity against all intracelular development stages of the genera Cystoisospora , that is, merogony (asexual multiplication) and gamogony (sexual phase).   FORCERIS ® is indicated for pigs aged 1-3 days of age for the concomitant prevention of iron deficiency anemia and prevention of clinical signs of coccidiosis (diarrhea) as well as reduction in oocyst excretion in farms with a confirmed history of coccidiosis caused by Cystoisospora suis.]]></description>
            <pubDate>Tue, 27 Oct 2020 09:06:17 +0100</pubDate>
        </item>
        <item>
            <title>A Healthy Start Sets You Apart</title>
            <link>https://www.ceva.ph/News-Media/News/A-Healthy-Start-Sets-You-Apart</link>
            <guid>https://www.ceva.ph/News-Media/News/A-Healthy-Start-Sets-You-Apart</guid>
            <description><![CDATA[Forceris, an innovative injectable combination of gleptoferron and toltrazuril, was launched in the Philippines last September 3, 2020.]]></description>
            <pubDate>Sat, 24 Oct 2020 04:51:46 +0200</pubDate>
        </item>
        <item>
            <title>C Our Future: Ceva PH launch</title>
            <link>https://www.ceva.ph/News-Media/News/C-Our-Future-Ceva-PH-launch</link>
            <guid>https://www.ceva.ph/News-Media/News/C-Our-Future-Ceva-PH-launch</guid>
            <description><![CDATA[   On the 23 rd and 25 th of July 2019, Ceva Asia Think Tank Philippines launched the local office&#039;s Corporate Social Responsibility (CSR) project called C Our Future Movement. Two events, held at Shangri-La Hotel, Bonifacio Global City and Dusit Thani D2 Hotel, Davao City respectively were meant to touch base with over 50 of Ceva&#039;s top layer partners. The Philippine team, CSR PH representative Mary Joy Murillo works hand in hand with local Ceva We Give Back team Michelle Naje, Israel Montano, Joyce Melegrito and Michael Marcelo in the promotion and execution of a movement to help improve the nutritional status of Filipino children. Its objective is to send the message about “Embracing Chicken and Eggs to help break the cycle of child stunting.” This movement was initiated by Ceva Animal Health Asia which covers 9 countries.     There are 3 phases in this CSR project, the first of which is to raise awareness of the importance of chicken and eggs through social media. This will be followed by an actual feeding program phase in a select institution with children less than 5 years of age which will be made more successful and meaningful through synergistic partnership with our local poultry partners. ]]></description>
            <pubDate>Thu, 15 Aug 2019 08:20:12 +0200</pubDate>
        </item>
        <item>
            <title>Ceva’s Renewed Commitment to the Layer Segment Communicated through Novamune Launch</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-s-Renewed-Commitment-to-the-Layer-Segment-Communicated-through-Novamune-Launch</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-s-Renewed-Commitment-to-the-Layer-Segment-Communicated-through-Novamune-Launch</guid>
            <description><![CDATA[In July 23 and 25, 2019, Ceva PH formally launched its newest product, Novamune. This signaled their renewed commitment to the Philippine layer segment with Novamune, a layer-specific Infectious Bursal Disease (IBD) vaccine. With some of the biggest players in this industry, Novamune was introduced through the global campaign - Less is More . In the new Ceva program, hatchery vaccination with Novamune at the core is recommended as the preferred option because of the 53% reduction in vaccine application (from 19 applications to 9 applications). The hatchery program guarantees cost savings and stress reduction due to handling which is a culprit in unoptimized flock performance.     Discussions during the half day session included Dr. Fusun Gungor’s topic on Less is More which touched on Ceva’s new technology vaccines in a simplified vaccination program. Novamune differentiating features were clearly enumerated by Dr Mel Umandal while the local and international field trial results were presented by Dr Jay Peria.     As the Philippines breaks into the Asian livestock and poultry export market, a representative from the Bureau of Animal Industry (BAI) was invited to share the government’s initiatives and plans moving forward. Dr. Oscar Jhan Cabanayan tackled salient points on egg importation and layer farm accreditation to encourage local farmers to take part in the success of this opportunity. The audience actively participated as they posed challenging questions after the presentations and consulted with the experts on their specific flock health programs.   ]]></description>
            <pubDate>Wed, 7 Aug 2019 08:13:26 +0200</pubDate>
        </item>
        <item>
            <title>COGLAPEST</title>
            <link>https://www.ceva.ph/Products/Products-list/COGLAPEST</link>
            <guid>https://www.ceva.ph/Products/Products-list/COGLAPEST</guid>
            <description><![CDATA[  COGLAPEST ® is an attenuated live classical swine fever ( CSF/Hog Cholera ) vaccine prepared from the THIVERVAL strain and produced on homologous diploid cells. The THIVERVAL strain is a “cold” mutant of classical swine fever virus obtained by passaging many times in cell culture at low temperature.   This THIVERVAL strain provides:   Early appearance of immunity (5 - 12 days) High immunogenicity Long-lasting immunity after a single injection (4 - 8 months) Protection against all Hog Cholera variants Absence of pathogenicity No post-vaccinal reaction No teratogenicity No effect on fertility or fecundity]]></description>
            <pubDate>Fri, 26 Oct 2018 07:19:37 +0200</pubDate>
        </item>
        <item>
            <title>HYOGEN</title>
            <link>https://www.ceva.ph/Products/Products-list/HYOGEN</link>
            <guid>https://www.ceva.ph/Products/Products-list/HYOGEN</guid>
            <description><![CDATA[  - Single injection provides early and long lasting protection   - Broad stimulation of the immune system with Imuvant TM   - Trials demonstrate superior protection versus competitors   - Expertise of the Ceva Lung Program]]></description>
            <pubDate>Fri, 26 Oct 2018 06:31:57 +0200</pubDate>
        </item>
        <item>
            <title>CEVAC® MD RISPENS</title>
            <link>https://www.ceva.ph/Products/Products-list/CEVAC-R-MD-RISPENS</link>
            <guid>https://www.ceva.ph/Products/Products-list/CEVAC-R-MD-RISPENS</guid>
            <description><![CDATA[Cevac® MD Rispens is recommended for to be used for active immunization of chicken for in-ovo vaccination in 18-19 day old embryonated eggs and in day-old chicks as an aid in the prevention of Marek&#039;s disease caused by the Marek&#039;s disease virus.]]></description>
            <pubDate>Wed, 6 Jun 2018 06:01:39 +0200</pubDate>
        </item>
        <item>
            <title>CEVAC® IBIRD</title>
            <link>https://www.ceva.ph/Products/Products-list/CEVAC-R-IBIRD</link>
            <guid>https://www.ceva.ph/Products/Products-list/CEVAC-R-IBIRD</guid>
            <description><![CDATA[Cevac® IBird is recommended for the vaccination of chickens in order to reduce the respiratory clinical signs caused by variant strains of infectious bronchitis virus]]></description>
            <pubDate>Wed, 6 Jun 2018 04:45:22 +0200</pubDate>
        </item>
        <item>
            <title>TRANSMUNE </title>
            <link>https://www.ceva.ph/Products/Products-list/TRANSMUNE</link>
            <guid>https://www.ceva.ph/Products/Products-list/TRANSMUNE</guid>
            <description><![CDATA[TRANSMUNE®IBD: IMMUNE COMPLEX TECHNOLOGY AGAINST IBD. Infectious Bursal Disease (IBD) has been a long standing challenge in the field. Producers needed a vaccine that worked in the presence of a relatively high level of maternal antibodies. In response, Ceva developed Transmune® IBD, a vaccine breaking through the Maternal antibodies barrier to reach the bursa. Consequently, it is providing an homogeneous and lifetime protection with a single dose administered via in ovo (in the egg) or subcutaneous injection.]]></description>
            <pubDate>Thu, 31 May 2018 03:57:16 +0200</pubDate>
        </item>
        <item>
            <title>Vaccines</title>
            <link>https://www.ceva.ph/Products/Swine/Vaccines/Vaccines</link>
            <guid>https://www.ceva.ph/Products/Swine/Vaccines/Vaccines</guid>
            <description><![CDATA[Ceva is committed to swine vaccines with its Research and Development sites located in different continents worldwide investing substantial resources in innovation and production. This process has been accelerated during the last years, but it has its...]]></description>
            <pubDate>Tue, 29 May 2018 15:27:33 +0200</pubDate>
        </item>
        <item>
            <title>Ceva New Technology Summit Philippines: a sneak peek into the future of poultry farming</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-New-Technology-Summit-Philippines-a-sneak-peek-into-the-future-of-poultry-farming</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-New-Technology-Summit-Philippines-a-sneak-peek-into-the-future-of-poultry-farming</guid>
            <description><![CDATA[Ceva holds a forum for poultry industry stakeholders in Manila, Philippines on May 3.]]></description>
            <pubDate>Tue, 29 May 2018 15:09:10 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Santé Animale Given European Commission Go Ahead to Acquire Merial Assets from Boehringer Ingelheim </title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Sante-Animale-Given-European-Commission-Go-Ahead-to-Acquire-Merial-Assets-from-Boehringer-Ingelheim</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Sante-Animale-Given-European-Commission-Go-Ahead-to-Acquire-Merial-Assets-from-Boehringer-Ingelheim</guid>
            <description><![CDATA[The European Commission recently gave its approval for the transfer to Ceva Santé Animale of nine products developed and currently marketed by Merial.]]></description>
            <pubDate>Mon, 20 Feb 2017 13:57:23 +0100</pubDate>
        </item>
        <item>
            <title>CIRCOVAC</title>
            <link>https://www.ceva.ph/Products/Products-list/CIRCOVAC</link>
            <guid>https://www.ceva.ph/Products/Products-list/CIRCOVAC</guid>
            <description><![CDATA[Circovac® is Ceva’s vaccine against porcine circovirus type 2. It is registered for use in both piglets and sows. The vaccine is a “whole-virus” vaccine, thus inducing immunity against both ORF-1 and ORF-2. Protection is demonstrated against PCV2a, PCV2b and PCV2d.]]></description>
            <pubDate>Thu, 28 Jul 2016 14:07:05 +0200</pubDate>
        </item>
        <item>
            <title>Top Swine Veterinary Practitioner Group partners with Ceva Philippines for New Learnings</title>
            <link>https://www.ceva.ph/News-Media/News/Top-Swine-Veterinary-Practitioner-Group-partners-with-Ceva-Philippines-for-New-Learnings</link>
            <guid>https://www.ceva.ph/News-Media/News/Top-Swine-Veterinary-Practitioner-Group-partners-with-Ceva-Philippines-for-New-Learnings</guid>
            <description><![CDATA[The Philippine Porcine Practitioners, Inc (PPPI), the most prestigious professional swine organization in the country held its first exclusive continuing education initiative and invited Ceva Animal Health (Philippines) as its knowledge partner.   The first Swine Key Opinion Leader (KOL) expert panel meet was spearheaded by Dr. Michael Quilitis, Veterinary Technical Services (VTS) Manager last March 14 at the Eugenio Lopez Center in Antipolo City. The sessions were ably facilitated by the Asia Swine Veterinary Services Manager, Dr. Metta Makhanon and supported by the local Ceva team and Dr. Mark Mombarg, Asia Swine Franchise Manager.   Discussions were lively as the various topics on Porcine Respiratory Disease Complex (PRDC), Porcine Circovirus (PCV) and Porcine Reproductive and Respiratory Syndrome (PRRS) were tackled. Dr. Zoilo Lapus, a respected senior veterinarian commented that the topics were “very informative” and “practical”. The high engagement level and learnings were well appreciated by the group. The PPPI has invited Ceva Philippines to conduct a follow-up learning session within 2018.   ]]></description>
            <pubDate>Thu, 28 Jul 2016 13:38:56 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Animal Health Philippines Enters Neonatal Coccidiosis Market with Cevazuril</title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Animal-Health-Philippines-Enters-Neonatal-Coccidiosis-Market-with-Cevazuril</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Animal-Health-Philippines-Enters-Neonatal-Coccidiosis-Market-with-Cevazuril</guid>
            <description><![CDATA[Last April 15, Ceva Animal Health Philippines invited selected some of the Philippines’ biggest swine raisers and key opinion leaders as it launched Cevazuril during the Hog Raisers Convention at the SMX Convention Center in Bacolod City.     The intimate dinner affair was opened by Ceva Philippines’ Country Manager Levi Directo where 75 of the most relevant clients were invited. The technical discussion was handled smoothly by our key speaker, Dr Mark Mombarg and followed by a lively and lengthy exchange of opinions between Dr. Mark Mombarg and his audience. This furthered the interest of those in attendance to try Cevazuril as the most logical and cost-beneficial alternative to the only locally available branded product.  ]]></description>
            <pubDate>Mon, 6 Jun 2016 08:26:18 +0200</pubDate>
        </item>
        <item>
            <title>Ceva Animal Health Philippines joins the 25th National Hog Convention </title>
            <link>https://www.ceva.ph/News-Media/News/Ceva-Animal-Health-Philippines-joins-the-25th-National-Hog-Convention</link>
            <guid>https://www.ceva.ph/News-Media/News/Ceva-Animal-Health-Philippines-joins-the-25th-National-Hog-Convention</guid>
            <description><![CDATA[Ceva Animal Health Philippines exhibited its distinct products and services to hog raisers in the Philippines during the 25th National Hog Convention held at the SMX Convention City in Bacolod City, an island in Southern Philippines. It is an annual event organized by a majority of the largest swine raisers in the country that aims to bring updates and new technology to the swine industry. It is participated in by over a two thousand farm raisers from small-scale raisers to integrated farm operations and a majority of the Philippine veterinary drug companies.     The three day event comprised of meetings among swine raisers on best practices and continuing education initiatives spearheaded by experts from the veterinary drug industry. We showcased our technical expertise through Ceva’s Veterinary Technical Services, particularly the Ceva Lung Program discussed by Dr. Mike Quilitis and a Repronomics presentation ably handled by Dr Donnan Canoy. Inquiries from farmers started to pour in after on how these could benefit their swine operations.  ]]></description>
            <pubDate>Mon, 6 Jun 2016 08:24:01 +0200</pubDate>
        </item>
        <item>
            <title>Newcastle Disease Issues Prompts Ceva Philippines’ to Extend Expertise to Farmers</title>
            <link>https://www.ceva.ph/News-Media/News/Newcastle-Disease-Issues-Prompts-Ceva-Philippines-to-Extend-Expertise-to-Farmers</link>
            <guid>https://www.ceva.ph/News-Media/News/Newcastle-Disease-Issues-Prompts-Ceva-Philippines-to-Extend-Expertise-to-Farmers</guid>
            <description><![CDATA[The Northern part of Luzon, Philippines’ biggest island has been challenged early this year by Newcastle disease (ND) which resulted in significant damages that left farmers grasping for answers and remedies.      In response to numerous requests for assistance, Ceva Animal Health Philippines immediately went out to investigate reports. The Philippine government, through the Bureau of Animal Industry has actively sought Ceva’s expert opinion and assistance on the virus which we identified to be Genotype VIIi. The local Ceva team proudly emphasized that Ceva ND vaccine users had very low casualty reports with 85% of Transmune users already using it with Vectormune ND (under the Perfect Pair program).     Ceva stepped up the support to poultry industry key stakeholders as it intensified aid to farm partners through visits, necropsies, lab tests and recently, a continuing education tour on the ND problem. This endeavor involved tackling issues head on as authorities in poultry diseases were invited to share their experiences. The series of seminars kicked off in Manila in April 5 with two speakers, Dr Dennis Umali of the University of the Philippines Los Banos entitled “Advances in Disease Diagnosis in Poultry and Livestock” where he tackled topics relative to DNA sequencing, and our very own Dr Christophe Cazaban, Knowledge Manager, Innovation Strategy Department, Ceva Sante Animale, who shared ideas through his topic “Newcastle Disease Control and Prevention: A New Perspective”. The guests were composed of poultry key opinion leaders mainly veterinarians (KOL) handling cases involving a substantial number of birds.   Visits to key provinces in the islands of Visayas and Mindanao followed in succeeding days which were well-attended and the level of engagement was high. The local Veterinary Technical Services Managers Dr Mel Umandal and Dr Jay Peria also contributed presentations to help the Visayas and Mindanao veterinarians fight against and prepare for ND challenges better.    ]]></description>
            <pubDate>Mon, 6 Jun 2016 08:18:45 +0200</pubDate>
        </item>
        <item>
            <title>New Apps and Egginject Showcased by Ceva Philippines at the INAHGEN Farmers Congress 2016.</title>
            <link>https://www.ceva.ph/News-Media/News/New-Apps-and-Egginject-Showcased-by-Ceva-Philippines-at-the-INAHGEN-Farmers-Congress-2016</link>
            <guid>https://www.ceva.ph/News-Media/News/New-Apps-and-Egginject-Showcased-by-Ceva-Philippines-at-the-INAHGEN-Farmers-Congress-2016</guid>
            <description><![CDATA[Ceva Philippines joined one of the biggest expos in 2016, the International Animal Health, Genetics and Nutrition (INAHGEN) Congress held last February 24-26, 2016. INAHGEN boasted of having over 400 exhibitors and 40,000 local and international guests during the three day exhibition.   The Ceva teams showcased their latest offerings aimed at improving farm productivity through quality and value-based products, services and equipment.   The Ceva Swine Team shared the latest app offerings – Ceva Lung Program (CLP), Respi-nomics and Repro-nomics through short in-booth demonstrations and one-on-one tutorial sessions with engaged customers.    The Ceva swine team aims to be a significant player and the center of knowledge in swine respiratory and reproductive health. Part of their endeavor includes sharing updates on how to quickly and accurately monitor, assess and address concerns in the above mentioned segments.   As market leader in the poultry biologicals segment, numerous broiler and layer farmers visited to discuss and consult with the Ceva Poultry Team experts on relevant avian disease issues as well as appropriate health programs for their operations. Even notable personnel from the Bureau of Animal Industry also stopped by to discuss the ND reports in North Luzon with Ceva Poultry experts.   Guests were treated to a surprise with the Compact Egginject display which was also a highlight of Ceva’s participation.    The display provided potential customers the opportunity to appreciate the device at a more intimate distance. The audio-visual presentation playing next to the Egginject provided more insight on the machine’s capabilities and allowed viewers to see it in action.   ]]></description>
            <pubDate>Mon, 6 Jun 2016 07:55:49 +0200</pubDate>
        </item>
        <item>
            <title>ALTRESYN®</title>
            <link>https://www.ceva.ph/Products/Products-list/ALTRESYN-R</link>
            <guid>https://www.ceva.ph/Products/Products-list/ALTRESYN-R</guid>
            <description><![CDATA[Composition Oral solution. Altrenogest 4.00 mg. Excipients: Butylhydroxyanisole (E320) 0.07 mg. Butylhydroxytoluène (E321) 0.07 mg.  Indications Pigs (sexually mature gilts). For the synchronization of oestrus.  Contra-indications Do not administer to pregnant animals or lactating animals or those suffering from uterine infection. Ensure the correct dose is administered daily as under-dosing can lead to the formation of cystic follicles. Special precautions to be taken by the person administering the veterinary medicinal product to animals. Avoid skin contact with the product. Pregnant women and women of childbearing age should avoid contact with the product or should exercise extreme caution when handling this product. Accidental spillage on the skin should be washed off immediately with soap and water. Seek medical advice.  Dosage Oral use. 20 mg Altrenogest (5 mL) per animal once a day for 18 consecutive days. Animals should be segregated and dosed individually. Add the product as a top dressing to the feed using the metering pump.  Withdrawal period Meat and offal: 9 days.   Presentation and storage Carton of 1 container of 360 mL pressurized container or 1080 mL and 540 mL non-pressurized containers. Protect from sunlight and do not expose to temperatures exceeding 50 °C.      Download:   ALTRESYN® Brochure.pdf (11.94 MB)]]></description>
            <pubDate>Tue, 26 May 2015 09:41:12 +0200</pubDate>
        </item>
        <item>
            <title>Our Recruitment process</title>
            <link>https://www.ceva.ph/Careers/Our-Recruitment-process</link>
            <guid>https://www.ceva.ph/Careers/Our-Recruitment-process</guid>
            <description><![CDATA[Through our commitment to animal health and well-being, Ceva contributes to essential human needs. Join us !]]></description>
            <pubDate>Fri, 22 May 2015 12:01:48 +0200</pubDate>
        </item>
        <item>
            <title>Distributors</title>
            <link>https://www.ceva.ph/Who-are-we/Ceva-in-the-Philippines/Distributors</link>
            <guid>https://www.ceva.ph/Who-are-we/Ceva-in-the-Philippines/Distributors</guid>
            <description><![CDATA[Microhealth Trading &amp;nbsp;- North Luzon   Swine &amp; Poultry   Address : Romulo Highway, Tarlac City   Contact No: +6345-9825322 or 33   Mobile No: +63918-9203888   Contact Person: Neneth Lim / Rochelle Bio Ace Marketing &amp;nbsp;- Luzon   Swine   Address: 147 Malipampang San Ildefonso , Bulacan Systematic Farming Corp. &amp;nbsp;- Luzon   Swine   Address: 20 Linaw St. Banawe, Quezon City&amp;nbsp;   Contact No: +632-7429351 to 53   Contact Person: Owen Arkansas &amp;nbsp;- North Luzon   Swine &amp; Poultry   Address: Blk 2 Lot 3 Brgy. Sta. Clara Sta. Maria, Bulacan   Contact No: +63922-8601230   Contact Person: Joseph Dizon / Nonoy EMG Animal Clinic &amp;nbsp;- Luzon   Swine   Address: P.Toress Cor. Obispo Obviar St. Lipa City, Batangas   Contact No: +6343- 7572260   Contact Person: Dr. Ed Genoso / Lovely Alabang Marketing &amp;nbsp;- South Luzon   Swine   Address: 4 Tayabas Bay Drive Sucat, Paranaque   Contact No: +632-8420840   Contact Person: Rudy Mangiyat KNN &amp;nbsp;- South Luzon   Poultry   Address: U-302 Bormaheco Condo Cor. Metropolitan and Zapote St. Makati City   &amp;nbsp;&amp;nbsp; 3 Dimasuay St. San Isidreo Bay Laguna c/o Dr. Chris Patawaran Marcon Nutrivet &amp;nbsp;- IloIlo / Bacolod   Swine &amp; Poultry   Address: 25 V. De Leon St. Iloilo City   Contact No: +6333-3378959 / +63917-3020133   Contact Person: Frank Limsui IJ Vet Trading &amp;nbsp;- Cebu / Bantayan Island   Poultry   Address: 2851 Singson Compound Guadalupe, Cebu City c/o Alvin Ong   &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Binaobao Bantayan, Bantayan Island Cebu City   &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Brgy. Cogon Poblacion, Liloan Cebu City   Contact No: +63906-4220118   Contact Person: Edrina Sales Fair Trading &amp;nbsp;- Cebu   Swine   Address: 904 D. Jakosalem St. Cebu City   Contact Person: Peterson D. Sepe Fair Trading &amp;nbsp;- Mindanao   Swine   Address: 145 Ramon Magsaysay Ave. Davao City   Contact No: +6382-22100121   Contact Person: Garvin Jeng Freshmed Agro Vet &amp;nbsp;- Mindanao   Poultry   Address: 26 Arellano St. Davao City   Contact No: +6382-2220034 / +63908-8636945   Contact Person: Elsinor Andaya]]></description>
            <pubDate>Sat, 28 Jul 2012 05:47:57 +0200</pubDate>
        </item>
        <item>
            <title>VETRIMOXIN® L.A.</title>
            <link>https://www.ceva.ph/Products/Products-list/VETRIMOXIN-R-L.A</link>
            <guid>https://www.ceva.ph/Products/Products-list/VETRIMOXIN-R-L.A</guid>
            <description><![CDATA[Amoxicillin Injectable suspension VETRIMOXIN® L.A.: is an injectable suspension (long-action amoxicillin) for the treatment of affections caused by susceptible organisms, and more particularly respiratory affections, neonatal diseases etc. Presented in its specific CLAS® container, patented by CEVA Animal Health, VETRIMOXIN® LA is a unique speciality that provides at the same time a quick and long lasting efficiency as well as a good comfort for the pig and for the farmer. COMPOSITION Amoxicillin (as trihydrate salt) ..................................15 g Excipient q.s .........................................................100 ml PROPERTIES Amoxicillin is an half synthetic penicillin. The long acting formulation allows the antibiotic to reach and maintain effective levels of Amoxicillin for 48 hours. The main advantages of Amoxicillin are: broad spectrum antibiotic - bactericidal action enhanced - excellent diffusion and high concentration into all tissues after single administration through intramuscular route - low percentage of linkage with serum proteins - quick therapeutic answers - no pain nor irritation at the injection site INDICATIONS Cattle, sheep, goat, pig:  Treatment of diseases due to germs sensitive to Amoxicillin. CONTRA-INDICATIONS  Do not administer to animals sensitive to penicillins. Do not administer to rabbits and rodents. DOSAGE AND ADMINISTRATION Intramuscular route. Shake well before use. Usual dosage is: 15 mg of Amoxicillin/ Kg body weight, as 1 ml of VETRIMOXIN® L.A. per 10 kg body weight. Dose can be repeated 48 hours later if necessary. Large volumes (&gt;20 ml) should be injected at two different injection sites. WITHDRAWAL PERIOD Meat and offal: 10 days. Milk: 2 days (4 milkings). PRESENTATION  100 ml, 250 ml, 500 ml vial. FOR ANIMAL TREATMENT ONLY From one country to another, product lines are adapted to local demand and regulatory requirements. All the products presented on this website are not present in all the Asian Pacific countries. Some specific requirements may exist in one country and not in another one. For further information, please take a look at the CEVA Animal Health site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons. ]]></description>
            <pubDate>Fri, 27 Jul 2012 08:05:12 +0200</pubDate>
        </item>
        <item>
            <title>VECTORMUNE®  ND</title>
            <link>https://www.ceva.ph/Products/Products-list/VECTORMUNE-R-ND</link>
            <guid>https://www.ceva.ph/Products/Products-list/VECTORMUNE-R-ND</guid>
            <description><![CDATA[VECTORMUNE ® ND contains a live frozen serotype 3 Marek (HVT) vector vaccine virus indicated for use in chicken. The HVT in Vectormune ® ND expresses key protective Newcastle vaccine virus. It is indicated as an aid in the prevention of Newcastle disease and Marek&#039;s disease in chicken.   Composition:   Frozen minimum titer of HVT-NDV is 3420 PFUs   Indication:   Recommended for use in day-old chicks or in 18 to 10 day-old embryonated chicken eggs as an aid in the prevention of Newcastle disease or day-old chicks   Dosage:   Day-old chicks: 0.2 mL subcutaneous injection   In-ovo: 0.1 mL/0.05 mL   Recommended age of vaccination:   Day-old chicks OR   18-19 day-old chick embryos   Precaution:   Do not take out of liquid nitrogen until ready to use.   Do not vaccinate within 21 days before slaughter.   Do not re-freeze vaccine.   Burn containers and all unused vaccines.   Withdrawal Period:   21 days   Presentation:   Vial - 2 mL in dewars with liquid nitrogen]]></description>
            <pubDate>Fri, 27 Jul 2012 07:53:10 +0200</pubDate>
        </item>
    </channel>
</rss>
